Fairpointe Capital’s Charles River Laboratories CRL Stock Holding History

Fairpointe Capital’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-214,129	Closed	-$15.1M	–	78
2015 Q2	$15.1M	Sell	214,129 -60,560	-22%	-$4.48M	0.21%	50
2015 Q1	$21.8M	Sell	274,689 -1,240,367	-82%	-$91.5M	0.29%	50
2014 Q4	$96.4M	Sell	1,515,056 -165,860	-10%	-$10.4M	1.27%	39
2014 Q3	$100M	Buy	1,680,916 +222	+0%	+$12.7K	1.34%	40
2014 Q2	$90M	Buy	1,680,694 +123,118	+8%	+$6.76M	1.2%	40
2014 Q1	$94M	Sell	1,557,576 -461,828	-23%	-$26.9M	1.28%	41
2013 Q4	$107M	Sell	2,019,404 -330,238	-14%	-$16.6M	1.56%	35
2013 Q3	$109M	Buy	2,349,642 +45,034	+2%	+$2.07M	1.83%	28
2013 Q2	$94.6M	Buy	+2,304,608	New	+$98.7M	1.9%	26

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

First Trust Advisors

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Acadian Asset Management

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Primecap Management

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $92.2B AUM 15.8% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return